A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials
John Simes, Merryn Voysey, Rachel O'Connell, Paul Glasziou, James D Best, Russell Scott, Christopher Pardy, Karen Byth, David R Sullivan, Christian Ehnholm, Anthony Keech
PLoS One | PUBLIC LIBRARY SCIENCE | Published : 2010
Fenofibrate Intervention and Event Lowering in Diabetes was supported by grants from Laboratoires Fournier SA, Dijon, France (now part of Solvay Pharmaceuticals), and the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.